Effect of angiotensin II and endothelin‐1 receptor blockade on the haemodynamic and hormonal changes after acute blood loss and after retransfusion in conscious dogs
- 17 March 2004
- journal article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 180 (4) , 319-328
- https://doi.org/10.1111/j.1365-201x.2004.01265.x
Abstract
Aim: This study investigates angiotensin II and endothelin‐1 mediated mechanisms involved in the haemodynamic, hormonal, and renal response towards acute hypotensive haemorrhage.Methods: Conscious dogs were pre‐treated with angiotensin II type 1 (AT1) and/or endothelin‐A (ETA) receptor blockers or not. Protocol 1: After a 60‐min baseline period, 25% of the dog's blood was rapidly withdrawn. The blood was retransfused 60 min later and data recorded for another hour. Protocol 2: Likewise, but preceded by AT1 blockade with i.v. Losartan. Protocol 3: Likewise, but preceded by ETA blockade with i.v. ABT‐627. Protocol 4: Likewise, but with combined AT1plus ETAblockade.Results: In controls, haemorrhage decreased mean arterial pressure (MAP) by approximately 25%, cardiac output by approximately 40%, and urine volume by approximately 60%, increased angiotensin II (3.1‐fold), endothelin‐1 (1.13‐fold), vasopressin (116‐fold), and adrenaline concentrations (3.2‐fold). Glomerular filtration rate and noradrenaline concentrations remained unchanged. During AT1 blockade, the MAP decrease was exaggerated (−40%) and glomerular filtration rate fell. During ETA blockade, noradrenaline increased after haemorrhage instead of adrenaline, and the MAP recovery after retransfusion was blunted. The decrease in cardiac output was similar in all protocols.Conclusions: Angiotensin II is more important than endothelin‐1 for the short‐term regulation of MAP and glomerular filtration rate after haemorrhage, whereas endothelin‐1 seems necessary for complete MAP recovery after retransfusion. After haemorrhage, endothelin‐1 seems to facilitate adrenaline release and to blunt noradrenaline release. Haemorrhage‐induced compensatory mechanisms maintain blood flow more effectively than blood pressure, as the decrease in cardiac output – but not MAP – was similar in all protocols.Keywords
This publication has 36 references indexed in Scilit:
- Haemodynamic and hormonal changes during haemorrhage in conscious dogs treated with an endothelin-A receptor antagonistClinical Science, 2002
- Angiotensin II receptor antagonistsThe Lancet, 2000
- The effect of angiotensin AT1 receptor blockade in the brain on the maintenance of blood pressure during haemorrhage in sheepActa Physiologica Scandinavica, 1997
- Effect of an Endothelin Antagonist on Hemodynamic Responses to Angiotensin IIHypertension, 1996
- Systemic Endothelin Receptor Blockade Decreases Peripheral Vascular Resistance and Blood Pressure in HumansCirculation, 1996
- Endothelin ET A and ET B Receptors Cause Vasoconstriction of Human Resistance and Capacitance Vessels In VivoCirculation, 1995
- Role of Endogenous Endothelin-1 in Experimental Renal Hypertension in DogsCirculation, 1995
- Effect of different endothelin receptor antagonists and of the novel non‐peptide antagonist Ro 46‐2005 on endothelin levels in rat plasmaFEBS Letters, 1993
- Endothelins: homeostatic and compensatory actions in the circulatory and endocrine systemsEndocrine Reviews, 1993
- The Endothelin Family of Peptides: Local Hormones with Diverse Roles in Health and Disease?Clinical Science, 1993